Ventas(US:VTR) ZACKSยท2025-07-31 18:11Core Insights - Ventas, Inc. (VTR) reported second-quarter 2025 normalized funds from operations (FFO) per share of 87 cents, exceeding the Zacks Consensus Estimate of 85 cents, marking a 9% increase year-over-year [1][8] - The company achieved revenues of $1.42 billion in the second quarter, surpassing the Zacks Consensus Estimate of $1.37 billion, and reflecting an 18.3% year-over-year growth [2][8] - Ventas has raised its guidance for 2025 normalized FFO per share to a range of $3.41-$3.46, compared to the previous range of $3.36-$3.46 [7][9] Financial Performance - Same-store cash net operating income (NOI) for the total property portfolio increased by 6.6% year-over-year to $485.3 million [2][4] - The senior housing operating portfolio (SHOP) saw a 13.3% increase in same-store cash NOI year-over-year, reaching $226.1 million, supported by a 5.3% growth in average monthly revenues per occupied room [4][8] - The outpatient medical and research (OM&R) portfolio's same-store cash NOI improved by 1.7% year-over-year to $135.9 million, while the triple-net leased portfolio's same-store cash NOI rose by 1% to $123.4 million [5][8] Balance Sheet and Liquidity - Ventas ended the second quarter of 2025 with cash and cash equivalents of $614.2 million, a significant increase from $182.3 million as of March 31, 2025 [6] - The company reported $4.7 billion of liquidity at the end of the quarter, up from $2.9 billion as of March 31, 2025, with a net debt to further adjusted EBITDA ratio of 5.6 [6] Future Guidance - The total same-store cash NOI growth for 2025 is estimated to be between 6% and 8%, with the SHOP segment expected to grow between 12% and 16% [7][9] - The OM&R portfolio's same-store cash NOI is projected to grow between 2.25% and 2.75%, while the triple-net leased same-store cash NOI is expected to decline between negative 1.0% and negative 0.5% [9]